1. /
  2. About us /
  3. Our people and structure /
  4. Our people /
  5. Joshua Hayward
Our people

Dr Joshua Hayward

Senior Research Officer

Taking students

Working groups

joshua.hayward@burnet.edu.au
Dr Joshua Hayward

Background

Dr. Hayward is a molecular virologist and computational biologist working within the Retroviral Biology and Antivirals research laboratory (RBA). His research involves the identification and characterisation of novel retroviruses in Australian mammals such as bats, and the immunological interface between bats and viruses. He is also involved in research focussed on the microbiome within the female reproductive tract and the metabolites that they produce, with respect to their impact on sexually transmitted infections. Dr. Hayward is a lecturer in molecular virology at Monash University and post-graduate supervisor of PhD and Honours students within the RBA.

Qualifications

  • 2016: PhD in Molecular Microbiology, Monash University, Australia
  • 2010: BScAdv(Hons), Monash University, Australia

Awards

  • 2020: Jim and Margaret Beever Fellowship
  • 2019: Australasian Virology Society Award
  • 2018: Harold Mitchell Foundation Postdoctoral Fellowship
  • 2018: Ian Potter Award
  • 2017: Australasian Virology Society Award
  • 2016: Harold Mitchell Foundation Postgraduate Fellowship
  • 2015: Monash University Teaching Commendation based on student evaluations
  • 2010: Monash University Department of Microbiology Ed Westaway Prize
  • 2010: Monash Vice Chancellor’s Honours-PhD Scholarship

Burnet publications

View 28 more
06 Jun 2024

Lactic acid produced by optimal vaginal Lactobacillus species potently inactivates HIV-1 by several mechanisms including promoting inhibition of virion-associated reverse transcriptase activity and viral RNA degradation

Research Square (Research Square)

Catherine L Latham, Muriel Aldunate, David Tyssen, Adam Johnson, Joshua A. Hayward, Rob J. Center, Paul A. Ramsland, Anna C. Hearps, Gilda Tachedjian, Muriel Aldunate

06 Jun 2024

Lactic acid produced by optimal vaginal Lactobacillus species potently inactivates HIV-1 by several mechanisms including promoting inhibition of virion-associated reverse transcriptase activity and viral RNA degradation

Research Square (Research Square)

Catherine L Latham, Muriel Aldunate, David Tyssen, Adam Johnson, Joshua A. Hayward, Rob J. Center, Paul A. Ramsland, Anna C. Hearps, Gilda Tachedjian, Muriel Aldunate

26 Feb 2024

KoRV-related retroviruses in diverse Australian and African rodent species

bioRxiv (Cold Spring Harbor Laboratory)

Joshua A. Hayward, Gilda Tachedjian

Current projects

View 5 more
Bat viruses and antiviral factors
Open to students

Bat viruses and antiviral factors

We’ve discovered Hervey pteropid gammaretrovirus, the first replication competent retrovirus circulating in Australian fruit bats, suggesting that bats can deal with multiple viral threats.

Impact of a vaginal microbiota metabolite on epithelium integrity and HIV susceptibility

Impact of a vaginal microbiota metabolite on epithelium integrity and HIV susceptibility

We investigate how a factor produced by optimal microbiota augments the cervicovaginal mucosal barrier to prevent HIV acquisition.

EVE-M®: enhancing the vaginal environment and microbiome

EVE-M®: enhancing the vaginal environment and microbiome

The vaginal microbiome is a key determinant of a women’s sexual and reproductive health. There is an unmet need for effective non-antibiotic-based strategies to target bacterial vaginosis and its adverse sequelae.

View 5 more

News and features

Why don’t most viruses make bats sick?

Why don’t most viruses make bats sick?

On this page